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Nowadays, in assisted reproduction laboratories, human
oocytes and embryos are cryopreserved by two main meth-
ods: vitrification or slow freezing.
During vitrification, the cells are converted to a glassy
state without ice-crystal formation by using a viscous
medium with a very high concentration of cryoprotectants
(Rall and Fahy, 1985; Yavin and Arav, 2007). However, dur-
ing slow freezing due to the progressive permeation of
some cryoprotectants as the ice crystals form in the cryo-
preservation solution, a glassy/vitrified state is also
obtained within the cell throughout the cooling procedure
(Vanderzwalmen et al., 2013). For this reason, since both
vitrified and slow-frozen oocytes have a vitrified cyto-
plasm, it can be postulated that the same warming proto-
col can be used for both. Furthermore, since for any given
concentration of cryoprotectant, the warming rates are
much faster than the critical cooling rates (Fahy et al.,
1987), the minimal concentration of cryoprotectant to pre-
vent crystallization during warming must be higher than
during cooling (Vanderzwalmen et al., 2012). In fact, in
most vitrification protocols or commercial kits, the cryo-
protectant concentration in the first warming solution is
approximately 1 mol/l (The Alpha Consensus Meeting,
2012), which is higher than the cryoprotectant concentra-
tion in both the freezing solution and the first thawing
solution for rapid thawing of slow-frozen oocytes or
embryos (e.g. for oocytes: 0.2–0.3 mol/l in freezing
solution, 0.3–0.5 mol/l in thawing solution; Bianchi
et al., 2007; Boldt et al., 2006; Fabbri et al., 2001; Par-
megiani et al., 2008a). This suggests that vitrification
warming solution could be used for thawing slow-frozen
oocytes/embryos.
For a number of reasons, but most of all for the guar-
anteed high survival rate, vitrification is increasingly used
worldwide, especially for oocytes (Edgar and Gook, 2012).
Nevertheless, to date, perhaps millions of slow-frozen
oocytes/embryos have already been stored in IVF cryo-
banks. Furthermore, IVF centres that have completely
switched their cryopreservation programme from slow
freezing to vitrification may still receive slow-frozen
oocytes/embryos from other centres, cryopreserved by
various different protocols. Nowadays, regulations recom-
mend the use of FDA/CE-marked thawing media approved
for human IVF; because the shelf life of these media is
usually short (some months), it becomes expensive to
keep available the appropriate thawing solution for any
slow freezing protocol. In this scenario, the possibility
of using a ‘universal medium’ to thaw any cell/tissue irre-
spective of the freezing protocol may simplify the man-
agement of thawing procedures. For all these reasons,
the aim of this study is to evaluate a rapid warming pro-
tocol for slow-frozen human oocytes based on the stan-
dard warming procedure for vitrification, to optimize
the survival rate and reduce costs by using the same solu-
tions for both slow freezing and vitrification warming. The
rapid warming protocol proposed in this study is poten-
tially applicable also to slow-frozen embryos at any stage
of cleavage.Materials and methods
Study population
Since April 2004, all patients undergoing an IVF treatment at
the GynePro Medical Centres, Bologna, Italy have had the
option of cryopreserving their surplus oocytes not insemi-
nated during the fresh cycle. This study was performed
between December 2012 and January 2013 on 216 sibling
oocytes obtained from 40 patients and cryopreserved via
slow freezing from April 2004 to November 2008. Patient
age (mean ± standard error) at time of freezing was
33.70 ± 0.77 years. The number of oocytes thawed/warmed
per patient was 5.40 ± 0.53.
Ethical approval
All the women included in this cryopreservation programme
were informed of the procedure and written consent was
obtained from each at the time of oocyte freezing. The
written consent included the option of oocyte donation
for research purposes before destruction, should the patient
decide to discontinue the cryostorage. A further agreement
was obtained from any patient before starting the study.
This study was approved by the Institutional Review Board
of the clinic (reference no. 15.10.2012, approved 3 Decem-
ber 2012).
Ovarian stimulation, oocyte retrieval and selection,
study design, and endpoints
Ovarian stimulation and oocyte retrieval and selection
before cryopreservation were performed as previously
described (Parmegiani et al., 2008a). For this study,
slow-frozen oocytes were randomized for either conven-
tional rapid thawing or rapid warming via vitrification
warming solutions. Randomization was performed by a
different embryologist to the operator who performed
oocyte thawing/warming using a specific software tool
(http://www.randomizer.org): for example, for six straws
containing slow-frozen oocytes, a randomized set, 1, 2, 6,
was generated, so oocytes in straws 1, 2 and 6 were thawed
by conventional rapid thawing and oocytes in straws 3, 4 and
5 were rapidly warmed. The primary outcome measure was
morphological assessment of survival at 2 h. Secondary out-
come measures were parthenogenetic development and
spindle/metaphase configuration.
Cryopreservation
The cryopreservation protocol consisted of a slow-cooling
method (Fabbri et al., 2001). Oocyte freezing solutions
(OocyteFreeze; Origio, Denmark) contained Dulbecco’s
phosphate-buffered saline (PBS) supplemented with human
serum albumin, alpha- and beta-globulins and 1,2-propane-
diol (PROH) and sucrose as cryoprotectants.
After washing in a PBS solution (Vial 1–OocyteFreeze;
Origio), oocytes were equilibrated for 10 min at room
temperature in 1.5 mol/l 1,2-PROH (Vial 2–OocyteFreeze,
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1.5 mol/l 1,2-PROH and 0.3 mol/l sucrose (Vial 3–Oocyte-
Freeze; rigio). Between one and three oocytes were loaded
in plastic straws (Paillette Cristal 133 mm; Cryo Bio System,
France) and transferred into an automated biological verti-
cal freezer (Kryo 360–1.7; Planer, UK). The cooling process
was initiated, reducing the chamber temperature from 20C
to 7C at a rate of 2C/min. Ice nucleation was induced
manually at 7C (seeding). After a hold time of 10 min at
7C, the straws were cooled slowly to 30C at a rate of
0.3C/min and then rapidly to 150C at a rate of 50C/min.
After 10–12 min at stabilization temperature, the straws
were transferred into liquid nitrogen and stored for later
use.
Rapid thawing
The straws were air-warmed for 30 s and then immersed in a
30C water bath for 40 s. The cryoprotectant was removed
at room temperature by stepwise dilution of PROH in the
thawing solutions: the contents of the straws were expelled
in 1.0 mol/l 1,2-PROH and 0.3 mol/l sucrose solution (Vial
1–OocyteThaw) and the oocytes were equilibrated for
5 min. The oocytes were then transferred into 0.5 mol/l
1,2-PROH and 0.3 mol/l sucrose solution (Vial 2–Oocyte-
Thaw) for 5 min and then into 0.3 mol/l sucrose solution
(Vial 3–OocyteThaw) for 10 min before final dilution in
PBS solution (Vial 4–OocyteThaw) for 20 min (10 min at
room temperature and 10 min at 37C). The oocytes were
finally cultured at 37C in ISM1 medium (Origio) in an atmo-
sphere of 6% CO2 in air for 2 h before assessment of survival.
Rapid warming
The straws were air-warmed for 10 s and then immersed in a
30C water bath until the external ice had melted (but not
for longer than 10 s because this is a critical step). Each
straw was opened and the content was immediately
expelled in 4 ml warming solution containing 1 mol/l
sucrose at 37C (Sucrose Warming Solution; Sage, USA).
Then, the oocytes were incubated at room temperature
for 3 min first in 0.5 mol/l Sucrose Warming Solution and
subsequently in 0.25 mol/l of 1:1 (v/v) of 0.5 mol/l Sucrose
Warming Solution and MOPS Solution (Sage) and finally
washed for 4 min in basic medium (MOPS Solution) before
culture. The oocytes were finally cultured at 37C in ISM1
medium in an atmosphere of 6% CO2 in air for 2 h before
assessment of survival.
Survival evaluation and oocyte destiny
After a 2-h post-thaw/post-warming culture, survival was
evaluated by inverted microscopy with Hoffman modulation
contrast. Oocytes were considered to have survived in the
absence of negative characteristics: dark or contracted
ooplasm, vacuolization, cytoplasmic leakage, abnormal per-
ivitelline space, cracked zona pellucida. Some of these sur-
viving oocytes were then studied either for their
developmental competence or for their spindle/metaphase
configuration, whereas 33 sibling oocytes taken from seven
patients were observed only for survival. The remainingoocytes were randomly assigned to parthenogenesis or
spindle study by a sealed envelope procedure: 96 sibling
oocytes taken from 26 patients were parthenogenetically
activated and 48 sibling oocytes taken from seven patients
were fixed and observed for spindle/chromosome
configuration.
Parthenogenetic activation
Two hours after thawing/warming, oocytes were exposed to
calcium-ionophore (GM508 Cult Active Mediuml Gynemed,
Germany) for 15 min at 37C with 6% CO2 in air then washed
twice and subsequently incubated in 2 mmol/l 6-dimethy-
laminopurine (Sigma–Aldrich, Italy) in ISM1 medium for
3 h at 37C with 6% CO2 in air. Oocytes were then washed
in fresh ISM1 medium, placed in 50-ll microdrops of the
same medium under oil (Ferticult Mineral oil; Fertipro, Bel-
gium) and cultured at 37C with 6% CO2 in air. After 18–20 h
(with exposure to calcium-ionophore as time 0) oocytes
were evaluated for signs of activation. Oocytes showing
one enlarged pronucleus and no extrusion of the second
polar body were considered activated (Loi et al., 1998). Par-
thenotes were kept in culture in ISM1 for 3 d, followed by a
further 2 d of culture in Blast Assist Medium (Origio). Par-
thenote development was assessed as previously described
(Paffoni et al., 2007), by counting the number of blasto-
meres at 42–44 h (day 2) and at 66–68 h (day 3) after acti-
vation; blastocyst formation was evaluated at 118–120 h
(day 5) after activation.
Assessment of meiotic spindle and chromosome
configuration
Two hours after thawing/warming, surviving oocytes were
fixed in 4% formaldehyde and used for the study of spindle
and chromatin organization as previously described (Antc-
zak and Van Blerkom, 1997; Cobo et al., 2008a; Messinger
and Albertini, 1991) but with a slightly modified procedure.
Briefly, the oocytes were washed with a solution of PBS (Life
Technologies, USA) with 3 mg/ml polyvinylpyrrolidone
(Sigma–Aldrich) and 0.01% Tween 20 (Bio-Rad Laboratories,
USA) and was successively treated with pronase type XIV
(Sigma–Aldrich) for 20 min at 37C for zona pellucida
removal. Permeabilization was performed with a PBS/PVP
solution supplemented with 0.5% Triton-X-100
(Sigma–Aldrich) for 1 h at 37C, followed by washing in
blocking solution consisting of PBS/PVP solution supple-
mented with 1.5% bovine serum albumin (Sigma–Aldrich)
for 2 h at 37C. Oocytes were further processed for immuno-
staining through overnight incubation with a monoclonal
primary anti-a tubulin antibody (Santa Cruz Biotechnology,
USA) diluted 1:100 in blocking solution, followed by incuba-
tion for 2 h at room temperature with secondary antibodies
conjugated with Alexa 488 (Life Technologies) diluted 1:500
in blocking solution; after each antibody incubation,
oocytes were washed in blocking solution. Chromatin
staining was performed by using 5 lg/ml Hoechst 33342
(Sigma–Aldrich) for 8 min at room temperature. After
washing, the oocytes were mounted with a mixture of glyc-
erol/PBS (I:I, v/v) and analysed by confocal microscopy (TCS
SP5 II; Leica Microsystems, Germany).
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fied as follows: (i) normal, if microtubules formed two
opposite poles; (ii) slightly aberrant, if microtubule struc-
tures displayed reduced dimensions of the spindle and lost
normal poles; (iii) aberrant, if disorganized microtubule
patterns were observed; and (iv) absent, if the spindle
was not found. Based on chromosomal distribution in the
metaphase plate, oocytes were classified as follows: (i) nor-
mal, in the case of normal distribution; (ii) misaligned, if
the plate showed some disorganization, with one or two
chromosomes separated from the plate; (iii) displaced, in
the case of scattered and decondensed chromosomes or dis-
organized chromosomal plate; and (iv) activated, if sister
chromatid separation was observed.
Statistical analysis
Calculation of sample size was based on this group’s previ-
ous study performed on 437 slow-frozen oocytes, with a sur-
vival rate after thawing of 75% (Parmegiani et al., 2008a).
This analysis revealed that at least 174 oocytes would be
necessary to obtain a confidence level of 95% and a margin
of error (confidence interval) of 5%. For this reason, the
study was performed on more than 200 oocytes. Continuous
variables are presented as mean ± standard error. Categori-
cal variables are presented as percentage. Normality of
distribution of continuous variables was assessed with a
Kolmogorov–Smirnov test (with Lillefor correction).
Between-group differences of normally distributed continu-
ous variables were assessed with parametric statistic
(Student’s t-test), whereas non parametric statistics
(Mann–Whitney rank sum test) were employed when the
normality test was not passed. Between-group differences
in noncontinuous variables were assessed using chi-squared
test with Yates correction if needed or with Fisher’s exact




The mean number of oocytes warmed/thawed per group
was comparable: 2.55 ± 0.29 in the rapid warming group
versus 2.85 ± 0.30 in the rapid thawing group. Survival rate
was 90.2% (92/102) in the rapid warming group versus 74.6%
(85/114) in the rapid thawing group (P = 0.005).
An interesting observation was that, during warming,
slow-frozen oocytes in the rapid warming group displayed
the behaviour typical of vitrified oocytes: as soon as the
oocytes were expelled from the straw, they tended to float
and appear vitreous in 1 mol/l sucrose solution; they subse-
quently shrank in 0.5 mol/l sucrose, and then in 0.25 mol/l
sucrose and the washing solution they progressively recov-
ered their original shape. (Parmegiani in The Alpha Consen-
sus Meeting, 2012). This similarity is due to the ideal sucrose
concentration (1 mol/l) and temperature (37C) in the first
warming solution, which both determine better osmolarity
conditions for propanediol dilution compared with the con-
ventional slow-freezing thawing solution used in the rapid
thawing group (0.3 mol/l sucrose, 1 mol/l propanediol;room temperature). For this reason it was critical to expel
the oocytes into the first warming solution at 37C as soon
as the external ice around the straw had melted to avoid
or minimize fluid exchanges between oocytes and melted
holding medium inside the straw. Rapidly warmed oocyte
were expelled in 1 mol/l sucrose at 37C still shrunken and
rehydration occurred within 1 min (Figure 1A, B); subse-
quently, the oocytes went through the same recovery pro-
cess as vitrified oocytes (Figure 1C–E). Full recovery of
the original cell shape is obtained after 10 min from expul-
sion from the straw, compared with 30 min for rapidly
thawed oocytes (Figure 1F–J). The rapid warming in
1 mol/l sucrose at 37C (which may better protect against
the risk of water recrystallization) and the faster dilution
of intracellular cryoprotectants may both contribute to
the significantly better performance of rapidly warmed
oocytes compared with rapidly thawed oocytes.
Parthenogenetic development
A total of 96 sibling oocytes from 26 patients were activated
for parthenogenesis. The patient age was 33.69 ±
0.94 years. In the rapid warming and the rapid thawing
groups, the parthenogenetic activation rate was compara-
ble (90.4% versus 81.8%, respectively). Parthenogenetic
development was comparable at day 2 (2.67 ± 0.42 blasto-
meres versus 2.00 ± 0.00 blastomeres, respectively); how-
ever, at day 3, the rapidly warmed parthenotes had
5.00 ± 0.47 blastomeres versus 3.56 ± 0.26 blastomeres for
the rapidly thawed parthenotes (P = 0.042). Blastocyst
development was comparable (10.6% versus 5.6%, respec-
tively). The results for parthenogenetic development are
summarized in Table 1.
Spindle/metaphase configuration
A total of 48 sibling oocytes taken from seven patients were
fixed and observed for meiotic spindle/metaphase configu-
ration. More specifically, in 35 sibling oocytes taken from
six patients, the meiotic spindle together with the meta-
phase asset was studied, and in 13 sibling oocytes taken
from one patient, only the metaphase asset was studied.
The mean patient age was 34.17 ± 2.50 years.
In the rapid warming and the rapid thawing groups, the
meiotic spindle was present in the majority of the oocytes
observed (94.4% and 88.2%, respectively; not significant).
No significant differences were observed between the two
groups in normal and abnormal spindle and metaphase plate
configurations. Nevertheless, a better trend in spindle res-
toration and normal spindle/chromosomal pattern was
observed in the rapid warming group. The results are sum-
marized in Table 2.
Discussion
Human reproductive cells can be cryopreserved either via
vitrification or via slow freezing. Especially for embryos
and oocytes, vitrification is increasingly used due to the high
survival rate obtainable, and this procedure is overtaking
slow freezing in human assisted reproduction treatment
(Edgar and Gook, 2012).
Figure 1 Rapid warming and rapid thawing of slow-frozen sibling oocytes. Slow-frozen sibling oocytes from the same patient were
warmed via rapid warming or via a conventional rapid thawing procedure. (A–E) A rapidly warmed oocyte was expelled into 1 mol/l
sucrose at 37C still shrunken (A) and its rehydration occurred within 1 min (B); then, it was moved to 0.5 mol/l sucrose, where it
shrank again (C); subsequently, in 0.25 mol/l sucrose (D) and washing solution (E), the oocyte completely recovered its original cell
shape. (F–J) A rapidly thawed oocyte was expelled in 0.3 mol/l sucrose at room temperature when intra/extracellular fluids (water
and cryoprotectants) had already been exchanged inside the cryostraw; for this reason, its shape was already partially recovered (F,
G); the oocyte remained partially rehydrated throughout the third step of thawing, in 0.3 mol/l sucrose solution (H–I) and fully
recovered its original shape only in the washing solution, at 30 min after its release from the straw (J).
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dures, despite the different behaviour of the cryopreserva-
tion medium when cooled below the solidification point
(vitrification medium appears ‘glassy’ whereas slow freezing
medium is ‘iced’ due to the presence of ice crystals), the
cell cytoplasm itself is converted from liquid to solid state
without formation of ice crystals. In other words, slow
freezing is just a method of intracellular vitrification with
ice being present in the extracellular compartment (Katkovet al., 2012). In fact, intracellular formation of ice crystals
has a detrimental effect on cellular organelles and mem-
branes and must therefore be avoided during both cooling
and thawing phases (Leibo et al., 1978; Luyet, 1937; Mazur
et al., 2005). This is ensured in different ways during
vitrification or slow freezing, but at the end of both these
procedures the cell is vitrified. ‘Vitrification’ is defined as
the conversion of a superviscous liquid into a glassy state
when it is cooled below its glass transition temperature
Table 1 Parthenogenetic development.
Parameter Rapid warming (n = 58) Rapid thawing (n = 60) P value
Survival rate 52 (89.7) 44 (73.3) 0.041
Activated oocytes 52 (2.00 ± 0.16) 44 (1.69 ± 0.22) NS
Parthenogenetic activation rate 47 (90.4) 36 (81.8) NS
Blastomeres on day 2 (42–44 h) 2.67 ± 0.42 2.00 ± 0.00 NS
Blastomeres one day 3 (66–68 h) 5.00 ± 0.47 3.56 ± 0.26 0.042
Blastocyst rate 5 (10.6) 2 (5.6) NS
Values are n (%), n (mean ± standard error) or mean ± standard error.
NS = not statistically significant.
Table 2 Spindle/metaphase configuration.
Parameter Rapid warming Rapid thawing
Meiotic spindle xxx
No. of oocytes observed 18 17
Oocytes displaying meiotic spindle
at 2 h from thawing/warming
17 (94.4) 15 (88.2)
x xxxx
Type of meiotic spindle xxx
Normal 8 (44.4) 4 (23.5)
Slightly aberrant 4 (22.2) 6 (35.3)
Aberrant 5 (27.8) 5 (29.4)
Absent 1 (5.6) 2 (11.8)
x xxxx
Chromosomal distribution xxx
No. of oocytes observed 23 25
Normal 10 (43.5) 9 (36.0)
Misaligned 5 (21.7) 6 (24.0)
Displaced 8 (34.8) 8 (32.0)
Activated 0 (0) 2 (8.0)
Values are n (%) unless otherwise stated. There were no statistically significant differences between the groups.
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cooling rate is fast enough to prevent the formation of
organized crystals; the probability of obtaining a glassy
state depends on the relationship between viscosity, cooling
rate and sample volume (Vajta and Kuwayama, 2006; Yavin
and Arav, 2007).
During vitrification for cryopreservation of reproductive
cells, cells are converted to the glassy state by using a vis-
cous medium with very high concentration of cryoprotec-
tants (Rall and Fahy, 1985). Two types of cryoprotectants
are involved in cell cryopreservation: intracellular, which
can permeate the cell membrane (e.g. ethylene glycol,
propanediol, dimethylsulphoxide) and extracellular, which
cannot permeate inside the cell (e.g. sucrose). During vitri-
fication, high concentrations of cryoprotectants in the hold-
ing medium (about 4.5–6.5 mol/l for intracellular and
about 0.5–1 mol/l for extracellular cryoprotectants) encap-
sulate the cell in a vitrifying sheath and, at the same time,
determine a viscous environment inside the cell (Vanderz-
walmen et al., 2013). The intracellular cryoprotectants per-
meate the cell membrane and replace the inner water
which has drained out from the cell due to the very highosmotic gradient generated during the consecutive steps
of vitrification (in equilibration and vitrification solutions).
Subsequently the cells (loaded in specifically designed carri-
ers which allow fast cooling rates) vitrify by direct contact
with liquid nitrogen or exposure to nitrogen vapours
(Kuwayama et al., 2005; Parmegiani, 2011; Vajta and
Kuwayama, 2006; Yavin and Arav, 2007).
On the other hand, during slow freezing, the cryoprotec-
tant concentration in the cryopreservation medium is lower
than in the vitrification medium (about 1–2 mol/l for intra-
cellular and about 0.1–0.3 mol/l for extracellular cryopro-
tectants). During slow freezing, the cells are exposed to
this moderate concentration of extracellular cryoprotec-
tants which establish an osmotic gradient to facilitate a
progressive movement of water out of the cell (cell dehy-
dration), while intracellular cryoprotectants enter the cell,
replacing the intracellular water drawn out. At the end of
this dehydration process, intracellular cryoprotectants are
estimated to be approximately 1.5–1.7 mol/l (McGrath,
2009; Son and Tan, 2009). However, it must be pointed
out that, at the moment of cytoplasm solidification, intra-
cellular cryoprotectant concentration is postulated to be
620 L Parmegiani et al.higher than this. This is explained by the ‘solution effect’:
as the solution is cooled to lower and lower subzero temper-
atures, more of the water freezes and the solution becomes
increasingly concentrated (Leibo, 2008). Thus, as ice crys-
tals form and the osmolarity rises in the cryopreservation
solution, intracellular cryoprotectants continue to progres-
sively permeate the cell and further dehydration, shrinkage
and increase in intracellular solute concentration occur
(Leibo and Pool, 2011; Son and Tan, 2009). This happens
in the programmable freezer chamber during the seeding
of ice nucleation along the length of the straw/vial contain-
ing the cell; after this, the viscous cell cytoplasm is super-
cooled and converted to a glassy state (McGrath, 2009).
By using computerized predictive models, McGrath (2009)
calculated an intracellular cryoprotectant concentration
(1,2-propanediol) of 2.7 mol/l for human oocytes slow
cooled via a 0.3 mol/l sucrose protocol (Fabbri et al., 2001)
after 10 min holding time after ice nucleation seeding. At
this point the oocyte is postulated to be close to equilib-
rium, the freezer chamber temperature slightly decreases
at 0.3C/min from 7C to 20C and cell vitrification
occurs. In a recent paper, Vanderzwalmen et al. (2013)
demonstrated that cryoprotectant concentrations at the
moment of solidification inside slow-frozen mouse oocytes
are actually higher than inside vitrified oocytes (approxi-
mately 2.14 mol/l). This may be one of the reasons why
slow-frozen oocytes/embryos can survive the low thawing
rates (about 600C/min when straws/vials are air warmed
at 22–25C) during conventional slow freeze–thaw proto-
cols. In fact, warming speeds play an even more important
role for cell survival than cooling rates (Seki and Mazur,
2008, 2009). This is well accepted in the case of vitrifica-
tion, where a high warming speed (about 20,000C/min) is
critical to prevent cell lysis; if the warming speed is not fast
enough, the supercooled liquid is rapidly transformed into
ice crystals because intracellular cryoprotectant concentra-
tion is too low to prevent recrystallization (Vanderzwalmen
et al., 2012, 2013).
During the thawing/warming process, extracellular cryo-
protectants are used to generate an osmotic gradient which
favours cell rehydration and drains intracellular cryoprotec-
tants. Since for any given concentration of cryoprotectants,
the warming rates are much faster than the critical cooling
rates (Fahy et al., 1987), the minimum concentration of
cryoprotectant to prevent crystallization during warming
must be higher than during cooling (Vanderzwalmen et al.,
2012). This means that, when thawing slow-frozen
oocytes/embryos, vitrification warming solution could be
used to optimize cell survival because extracellular cryopro-
tectant concentration in the first warming solution in any
vitrification protocol is usually 1 mol/l, which is higher than
in slow-freezing thawing solution (e.g. 0.3–0.5 mol/l for
human oocytes). For this reason, this high extracellular
cryoprotectant concentration in the medium should better
protect against the risk of the recrystallization of the cellu-
lar water during warming. This was the rationale of the
present study, which tested the vitrification warming proto-
col on slow-frozen human oocytes, which are well known to
be the most sensitive reproductive cells during cryopreser-
vation/thawing process. Furthermore, predictive models
have suggested that there may be opportunities for optimiz-
ing the thawing protocol for oocytes slow frozen with0.3 mol/l sucrose (McGrath, 2009). As far as is known, this
study is the first to investigate the possibility of using vitri-
fication warming solution for thawing human oocytes.
Interestingly, the survival rate was significantly improved
when the slow-frozen oocytes were rapidly warmed (90.6%)
rather than thawed with the conventional procedure
(75.0%). In the rapid thawing group, the survival rate was
comparable to the survival previously reported in clinical
studies on oocytes slow frozen with 0.3 or 0.2 mol/l sucrose
(Bianchi et al., 2012; Parmegiani et al., 2008a,b, 2009a,b);
in fact, evidence from widespread practice suggests that a
plateau has been reached at 70–80% with currently avail-
able slow freezing/rapid thawing methodology (Edgar and
Gook, 2012; Gook and Edgar, 2007). On the other hand,
the rapidly warmed oocyte survival rate in the current study
(about 90%) is comparable with survival obtained in the
majority of vitrification studies (Edgar and Gook, 2012;
Kuwayama et al., 2005), particularly in those performed
on infertile patients (Parmegiani et al., 2011; Practice Com-
mittees of American Society for Reproductive Medicine and
Society for Assisted Reproductive Technology, 2013; Rienzi
et al., 2010; The Alpha Consensus Meeting, 2012).
Furthermore, rapidly warmed oocytes showed a better
development after parthenogenetic activation. Partheno-
genesis is a tool for the preclinical evaluation of experimen-
tal procedures, because the developmental competence of
activated oocytes is similar to fertilized oocytes (Paffoni
et al., 2007). The mean number of blastomeres in day 3
was significantly higher in rapid warming than in rapidly
thawed parthenotes, and this was comparable with that of
parthenotes derived from fresh oocytes in the study by Paff-
oni et al. (2007), as was the blastulation rate (about 10%).
These findings seem to demonstrate that it is possible to
increase the efficiency of oocyte slow freezing simply by
improving the thawing procedure.
This study also analysed the oocytes by confocal micros-
copy in order to observe the meiotic spindle rearrangement
dynamics (Bromfield et al., 2009). The human metaphase-II
oocyte has its chromosomes equatorially located on a
spindle, a temporary and dynamic structure of microtubules
which is very sensitive to cooling (Pickering et al., 1990). It
is already known that prolonged chilling at temperatures
about 0C is highly detrimental and causes oocyte meiotic
spindle disassembly (Zenzes et al., 2001). However, in
oocytes cryopreserved via slow freezing, the spindle should
be protected by intracellular cryoprotectants (George
et al., 1996; Gook et al., 1993; Van der Elst et al., 1988;
Yang et al., 2010). Nevertheless, spindle alterations and dis-
assembly have been displayed during the rapid thawing pro-
cedure (Coticchio et al., 2006; Rojas et al., 2004; Wu et al.,
2006). In studies with polarization microscopy, oocyte spin-
dles were identified immediately after thawing, disap-
peared during the subsequent removal of cryoprotectants
and finally reappeared after 3–5 h of culture (Bianchi
et al., 2005; Rienzi et al., 2004). On the contrary, during vit-
rification protocols, the meiotic spindle and chromosome
alignment are both maintained throughout the processes
of vitrification, warming and post warming (Chang et al.,
2011; Larman et al., 2007). Through the use of a vitrification
warming protocol on slow-frozen oocytes, the present study
might give interesting information on the mechanism of
spindle disruption/recovery during slow freezing. Thus,
Rapid warming of slow-frozen human oocytes 621spindle and chromosome dynamics were studied at 2 h from
thawing/warming in order to discover if different protocols
might influence spindle recovery. The presence of spindles
were observed in the majority of the oocytes; this is in
agreement with previous studies showing time-dependant
spindle repolymerization (Bianchi et al., 2005; Mandelbaum
et al., 2004; Pickering et al., 1990; Rienzi et al., 2004). Fur-
thermore, both normal spindle and chromosomal configura-
tion were comparable between the two study groups
(Table 2). Although slightly better figures for spindle pres-
ence and normal spindle/chromosome pattern may suggest
a better dynamic in the rapid warming group, the spindle
repolymerization does not seem to be influenced by the
choice of thawing/warming protocol, and it is at least clear
that the quick removal of intracellular cryoprotectants dur-
ing rapid warming does not negatively affect meiotic spindle
reformation.
Nowadays, human oocyte cryopreservation has moved
from bench-to-bedside and it is no longer considered an
experimental technique but a valuable clinical tool (ASRM
Practice Committee, 2012); this is due particularly to stud-
ies on vitrification demonstrating that vitrified oocytes per-
form as well as their fresh counterparts (Cobo et al., 2008b;
Parmegiani et al., 2011; Rienzi et al., 2010). The present
study demonstrates that it is possible to increase the sur-
vival of slow-frozen oocytes by changing the thawing proto-
col and to potentially obtain results comparable to
vitrification; furthermore, this study demonstrates that
the fast removal of intracellular cryoprotectants during
rapid warming does not negatively affect meiotic spindle
reformation. Even though oocyte slow freezing has been
optimized in the last 5 years (Bianchi et al., 2007, 2012; Par-
megiani et al., 2008a, 2009a), the oocyte still remains the
most fragile human cell with the highest risk of ice crystal
formation and cryoinjury during freezing/thawing, due to
an unfavourable nucleus/cytoplasm ratio and elevated
intracellular water concentration. Since the rapid warming
procedure proposed in this study is viable for oocytes, it is
also potentially applicable to other less fragile reproductive
cells frozen via slow freezing, such as zygotes or embryos at
any stage of cleavage (from 2 cells to blastocyst). A recent
prospective study performed on 359 slow-frozen pronuclear
embryos in Japan confirmed the positive effect on embryo
development of the rapid warming protocol: the blastocyst
formation rate was significantly increased when the
embryos were warmed with vitrification warming media
rather than with conventional rapid thawing (Kojima
et al., 2012). Furthermore, since in any protocol or com-
mercial kit, vitrification warming solutions have a concen-
tration of 1 mol/l (first warming step) and 0.5 mol/l
(second warming step) of extracellular cryoprotectants,
these solutions can be used for the warming of any repro-
ductive cell irrespective of the freezing protocols, thus
streamlining laboratory activity and potentially reducing
costs.
In conclusion, this is a pilot study that need confirmation
in large-scale clinical studies but, if these preliminary data
are confirmed, this finding will redefine the scenario of slow
freezing and vitrification, as it emphasizes the pivotal role
of warming and indicates that the results obtained until
now with slow freezing/rapid thawing can be improved.
The application of this warming protocol increased theefficiency of the oocyte/embryo slow freezing procedure,
enabling survival rates comparable with those reported in
vitrification studies. This could be the biggest breakthrough
in human oocyte cryopreservation since the introduction of
vitrification. Furthermore, this finding demonstrates that it
is possible to optimize the management of cryopreservation
cycles in the IVF laboratory by using a single warming proto-
col for both slow-frozen and vitrified oocytes and poten-
tially other reproductive cells.Acknowledgements
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